von Wyl V - Search Results

1

Non-equivalent, but still valid: Establishing the construct validity of a consumer fitness tracker in persons with multiple sclerosis.

Polhemus A, Sieber C, Haag C, Sylvester R, Kool J, Gonzenbach R, von Wyl V. Polhemus A, et al. Among authors: von wyl v. PLOS Digit Health. 2023 Jan 25;2(1):e0000171. doi: 10.1371/journal.pdig.0000171. eCollection 2023 Jan. PLOS Digit Health. 2023. PMID: 36812638 Free PMC article.

2

The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection.

Yerly S, Junier T, Gayet-Ageron A, Amari EB, von Wyl V, Günthard HF, Hirschel B, Zdobnov E, Kaiser L; Swiss HIV Cohort Study. Yerly S, et al. Among authors: von wyl v. AIDS. 2009 Jul 17;23(11):1415-23. doi: 10.1097/QAD.0b013e32832d40ad. AIDS. 2009. PMID: 19487906

3

Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked.

Huber M, von Wyl V, Ammann CG, Kuster H, Stiegler G, Katinger H, Weber R, Fischer M, Stoiber H, Günthard HF, Trkola A. Huber M, et al. Among authors: von wyl v. J Virol. 2008 Apr;82(8):3834-42. doi: 10.1128/JVI.02569-07. Epub 2008 Jan 30. J Virol. 2008. PMID: 18234794 Free PMC article. Clinical Trial.

4

Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring.

von Wyl V, Cambiano V, Jordan MR, Bertagnolio S, Miners A, Pillay D, Lundgren J, Phillips AN. von Wyl V, et al. PLoS One. 2012;7(8):e42834. doi: 10.1371/journal.pone.0042834. Epub 2012 Aug 8. PLoS One. 2012. PMID: 22905175 Free PMC article.

5

Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors.

Scherrer AU, von Wyl V, Böni J, Yerly S, Klimkait T, Bürgisser P, Garzoni C, Hirschel B, Cavassini M, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Günthard HF; Swiss HIV Cohort Study (SHCS). Scherrer AU, et al. Among authors: von wyl v. J Acquir Immune Defic Syndr. 2011 May 1;57(1):24-31. doi: 10.1097/QAI.0b013e318211925e. J Acquir Immune Defic Syndr. 2011. PMID: 21283013

6

Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types.

von Wyl V, Yerly S, Böni J, Bürgisser P, Klimkait T, Battegay M, Furrer H, Telenti A, Hirschel B, Vernazza PL, Bernasconi E, Rickenbach M, Perrin L, Ledergerber B, Günthard HF; Swiss HIV Cohort Study. von Wyl V, et al. Arch Intern Med. 2007 Sep 10;167(16):1782-90. doi: 10.1001/archinte.167.16.1782. Arch Intern Med. 2007. PMID: 17846398

7

Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection.

Huber M, Fischer M, Misselwitz B, Manrique A, Kuster H, Niederöst B, Weber R, von Wyl V, Günthard HF, Trkola A. Huber M, et al. Among authors: von wyl v. PLoS Med. 2006 Nov;3(11):e441. doi: 10.1371/journal.pmed.0030441. PLoS Med. 2006. PMID: 17121450 Free PMC article.

8

African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study.

Müller V, von Wyl V, Yerly S, Böni J, Klimkait T, Bürgisser P, Ledergerber B, Günthard HF, Bonhoeffer S; Swiss HIV Cohort Study. Müller V, et al. Among authors: von wyl v. AIDS. 2009 Jun 19;23(10):1269-76. doi: 10.1097/QAD.0b013e32832d4096. AIDS. 2009. PMID: 19461503

9

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

Gupta RK, Hill A, Sawyer AW, Cozzi-Lepri A, von Wyl V, Yerly S, Lima VD, Günthard HF, Gilks C, Pillay D. Gupta RK, et al. Among authors: von wyl v. Lancet Infect Dis. 2009 Jul;9(7):409-17. doi: 10.1016/S1473-3099(09)70136-7. Lancet Infect Dis. 2009. PMID: 19555900

10

Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.

Alizon S, von Wyl V, Stadler T, Kouyos RD, Yerly S, Hirschel B, Böni J, Shah C, Klimkait T, Furrer H, Rauch A, Vernazza PL, Bernasconi E, Battegay M, Bürgisser P, Telenti A, Günthard HF, Bonhoeffer S; Swiss HIV Cohort Study. Alizon S, et al. Among authors: von wyl v. PLoS Pathog. 2010 Sep 30;6(9):e1001123. doi: 10.1371/journal.ppat.1001123. PLoS Pathog. 2010. PMID: 20941398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page